Skip to content

Clinical trials

Withdrawn Phase 3 Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 3 Status: Withdrawn Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20141
20162

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Biogen1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Flowonix Medical1
GW Research Ltd1
Johns Hopkins University1
Novartis Pharmaceuticals1
RVL Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis8
Multiple Sclerosis, Relapsing-Remitting3
Muscle Spasticity2
Brain Injuries1
Cerebral Palsy1
Cognitive Dysfunction1
Multiple Sclerosis, Chronic Progressive1
Nervous System Diseases1
Neurodegenerative Diseases1
Recurrence1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.